Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low mitochondrial DNA copy number induces chemotherapy resistance via epithelial-mesenchymal transition by DNA methylation in esophageal squamous cancer cells

29 Aug 2022

Abstract excerpt

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is one of the most severe cancers and is characterized by chemotherapy resistance and poor prognosis associated with epithelial-mesenchymal transition (EMT). In a previous study, a low mitochondrial DNA (mtDNA) copy number was associated with poorer prognosis and induced EMT in ESCC. However, the detailed mechanism related to mtDNA copy number and EMT is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Esophageal Cancer Research and Treatment
Share to Mitochondrial Function and Pathology

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36038893
DOI: 10.1186/s12967-022-03594-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 20 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low mitochondrial DNA copy number induces chemotherapy resistance via epithelial-mesenchymal transition by DNA methylation in esophageal squamous cancer cellsPMID 36038893Read ↗

Esophageal squamous cell carcinoma with low mitochondrial copy number has mesenchymal and stem-like characteristics, and contributes to poor prognosisSemantic proximity Read ↗

D-loop mutations in mitochondrial DNA are a risk factor for chemotherapy resistance in esophageal cancer.Semantic proximity Read ↗

Identification of abnormal nuclear and mitochondrial genes in esophageal cancer cells.Semantic proximity Read ↗

Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis.Semantic proximity Read ↗

DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancerSemantic proximity Read ↗

Low copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in early-stage laryngeal cancer patientsSemantic proximity Read ↗

The role of mitochondrial DNA alterations in esophageal squamous cell carcinomas.Semantic proximity Read ↗

Low copy number and low oxidative damage of mitochondrial DNA are associated with tumor progression in lung cancer tissues after neoadjuvant chemotherapySemantic proximity Read ↗

Associated microsatellite alterations in mitochondrial DNA and in TP53 in thoracic esophageal squamous cell carcinoma.Semantic proximity Read ↗

Association of decreased mitochondrial DNA content with the progression of colorectal cancerSemantic proximity Read ↗

TET1 promotes cisplatin‐resistance via demethylating the vimentin promoter in ovarian cancerSemantic proximity Read ↗

Mitochondrial DNA copy number is associated with diagnosis and prognosis of head and neck cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.